Cellular Senescence in Lung Fibrosis
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Fibrosing interstitial lung diseases (ILDs) are chronic and ultimately fatal age-related lung diseases characterized by the progressive and irreversible accumulation of scar tissue in the lung parenchyma. Over the past years, significant progress has been made in our incomplete understanding of the pathobiology underlying fibrosing ILDs, in particular in relation to diverse age-related processes and cell perturbations that seem to lead to maladaptation to stress and susceptibility to lung fibrosis. Growing evidence suggests that a specific biological phenomenon known as cellular senescence plays an important role in the initiation and progression of pulmonary fibrosis. Cellular senescence is defined as a cell fate decision caused by the accumulation of unrepairable cellular damage and is characterized by an abundant pro-inflammatory and pro-fibrotic secretome. The senescence response has been widely recognized as a beneficial physiological mechanism during development and in tumour suppression. However, recent evidence strengthens the idea that it also drives degenerative processes such as lung fibrosis, most likely by promoting molecular and cellular changes in chronic fibrosing processes. Here, we review how cellular senescence may contribute to lung fibrosis pathobiology, and we highlight current and emerging therapeutic approaches to treat fibrosing ILDs by targeting cellular senescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 2×
“Evolutionary theories of the pathogenesis of lung fibrosis propose all the “hallmarks of aging” as major mechanisms of disease, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaus…”
BackgroundSelf-citationOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“The irreversibility was considered a key factor for discerning cellular senescence from quiescence and transient cell cycle arrest, bringing senescence into the spotlight as a cancer-suppressor and a possible contributor to aging [9,12,13].”
BackgroundSelf-citationEfficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103 · cited 1×
“IPF is a progressive, irreversible and fatal lung disease characterized by scarring and thickening of the interstitial lung tissue leading to cough, dyspnoea and, ultimately, respiratory failure and death [2,25].”
BackgroundA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · cited 1×
“As a response to lung injury, many interrelated woundhealing pathways are activated in order to facilitate the repair, turnover, and adaptation of lung tissue [7].”
BackgroundAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“It has been shown that aged and diseased tissues of multiple multicellular organisms are more abundant in senescent cells [10,31,32].”
BackgroundInfluentialNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citation
Research works printed but not linked: 50
- Wynn, 2007, Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases, J. Clin. Investig., 117, 524, 10.1172/JCI31487 · DOI · Paper page
- Travis, 2013, An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, Am. J. Respir. Crit. Care Med., 188, 733, 10.1164/rccm.201308-1483ST · DOI · Paper page
- Kapetanaki, 2013, Influence of age on wound healing and fibrosis, J. Pathol., 229, 310, 10.1002/path.4122 · DOI · Paper page
- Wynn, 2011, Integrating mechanisms of pulmonary fibrosis, J. Exp. Med., 208, 1339, 10.1084/jem.20110551 · DOI · Paper page
- Barkauskas, 2014, Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis, Am. J. Physiol. Cell Physiol., 306, C987, 10.1152/ajpcell.00321.2013 · DOI · Paper page
- Hayflick, 1965, The Limited in Vitro Lifetime of Human Diploid Cell Strains, Exp. Cell Res., 37, 614, 10.1016/0014-4827(65)90211-9 · DOI · Paper page
- Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
- Hornsby, 2002, Cellular senescence and tissue aging in vivo, J. Gerontol. A Biol. Sci. Med. Sci., 57, B251, 10.1093/gerona/57.7.B251 · DOI
- Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 · DOI · Paper page
- Hamsanathan, 2019, Cellular Senescence: The Trojan Horse in Chronic Lung Diseases, Am. J. Respir. Cell Mol. Biol., 61, 21, 10.1165/rcmb.2018-0410TR · DOI · Paper page
- Selman, 2014, Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model, Am. J. Respir. Crit. Care Med., 189, 1161, 10.1164/rccm.201312-2221PP · DOI · Paper page
- Pardo, 2016, Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis, Ann. Am. Thorac. Soc., 13, S417, 10.1513/AnnalsATS.201605-341AW · DOI · Paper page
- Schneider, 2021, The aging lung: Physiology, disease, and immunity, Cell, 184, 1990, 10.1016/j.cell.2021.03.005 · DOI · Paper page
- Mora, 2017, Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease, Nat. Rev. Drug Discov., 16, 755, 10.1038/nrd.2017.170 · DOI · Paper page
- Kropski, 2014, A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia, Chest, 146, e1, 10.1378/chest.13-2224 · DOI
- Borie, 2009, Prevalence of telomere shortening in familial and sporadic pulmonary fibrosis is increased in men, Am. J. Respir. Crit. Care Med., 179, 1073, 10.1164/ajrccm.179.11.1073 · DOI
- Borie, 2018, Clinical implications of telomere dysfunction in lung fibrosis, Curr. Opin. Pulm Med., 24, 440, 10.1097/MCP.0000000000000506 · DOI
- Lopez, 2019, Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis, Respirology, 24, 146, 10.1111/resp.13423 · DOI
- Wiley, 2019, Secretion of leukotrienes by senescent lung fibroblasts promotes pulmonary fibrosis, JCI Insight, 4, e130056, 10.1172/jci.insight.130056 · DOI
- Chondrogianni, 2015, Proteasome activation: An innovative promising approach for delaying aging and retarding age-related diseases, Ageing Res. Rev., 23, 37, 10.1016/j.arr.2014.12.003 · DOI
- Kropski, 2015, Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease, Am. J. Respir. Crit. Care Med., 191, 417, 10.1164/rccm.201406-1162OC · DOI · Paper page
- Tanjore, 2013, Endoplasmic reticulum stress as a pro-fibrotic stimulus, Biochim. Biophys. Acta, 1832, 940, 10.1016/j.bbadis.2012.11.011 · DOI
- Baker, 2014, Proteasomes in lungs from organ donors and patients with end-stage pulmonary diseases, Physiol. Res., 63, 311, 10.33549/physiolres.932607 · doi:10.33549/physiolres.932607
- Semren, 2015, Regulation of 26S Proteasome Activity in Pulmonary Fibrosis, Am. J. Respir. Crit. Care Med., 192, 1089, 10.1164/rccm.201412-2270OC · DOI
- Jorgensen, E., Stinson, A., Shan, L., Yang, J., Gietl, D., and Albino, A.P. (2008). Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells. BMC Cancer, 8. · DOI · Paper page
- Lawson, 2008, Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: Association with altered surfactant protein processing and herpesvirus infection, Am. J. Physiol Lung Cell Mol. Physiol, 294, L1119, 10.1152/ajplung.00382.2007 · DOI · Paper page
- Bueno, 2012, Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis, Am. J. Respir. Cell Mol. Biol., 46, 748, 10.1165/rcmb.2011-0224OC · DOI
- Beller, 2004, Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis, Proc. Natl. Acad. Sci. USA, 101, 3047, 10.1073/pnas.0400235101 · DOI
- Phan, 1987, Leukotriene C4 binds to rat lung fibroblasts and stimulates collagen synthesis, Adv. Prostaglandin Thromboxane Leukot Res., 17B, 997
- Smirnova, 2016, Detection and quantification of epithelial progenitor cell populations in human healthy and IPF lungs, Respir. Res., 17, 83, 10.1186/s12931-016-0404-x · DOI
- Xu, 2016, Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis, JCI Insight, 1, e90558, 10.1172/jci.insight.90558 · DOI · Paper page
- Mora, 2017, Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis, J. Clin. Investig., 127, 405, 10.1172/JCI87440 · DOI · Paper page
- Cheng, P., Li, S., and Chen, H. (2021). Macrophages in Lung Injury, Repair, and Fibrosis. Cells, 10. · DOI · Paper page
- Takenouchi, 2020, Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts, Exp. Cell Res., 391, 112010, 10.1016/j.yexcr.2020.112010 · DOI
- Chung, 2021, IGF-1 Receptor Signaling Regulates Type II Pneumocyte Senescence and Resulting Macrophage Polarization in Lung Fibrosis, Int. J. Radiat. Oncol. Biol. Phys., 110, 526, 10.1016/j.ijrobp.2020.12.035 · DOI
- Rana, 2020, PAI-1 Regulation of TGF-beta1-induced Alveolar Type II Cell Senescence, SASP Secretion, and SASP-mediated Activation of Alveolar Macrophages, Am. J. Respir. Cell. Mol. Biol., 62, 319, 10.1165/rcmb.2019-0071OC · DOI · Paper page
- Popescu, 2019, Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres, Am. J. Respir. Crit. Care Med., 199, 362, 10.1164/rccm.201805-0825OC · DOI
- Cardenes, 2018, Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis, Stem Cell Res. Ther., 9, 257, 10.1186/s13287-018-0970-6 · DOI · Paper page
- Liu, 2020, Senescent Mesenchymal Stem Cells: Disease Mechanism and Treatment Strategy, Curr. Mol. Biol Rep., 6, 173, 10.1007/s40610-020-00141-0 · DOI · Paper page
- Antoniou, 2021, Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care, Curr. Opin. Pharmacol., 57, 71, 10.1016/j.coph.2020.12.007 · DOI
- Martel, 2020, Emerging use of senolytics and senomorphics against aging and chronic diseases, Med. Res. Rev., 40, 2114, 10.1002/med.21702 · DOI · Paper page
- Eid, 2010, AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes, J. Biol. Chem., 285, 37503, 10.1074/jbc.M110.136796 · DOI · Paper page
- Feng, 2006, Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence, Cell Cycle, 5, 2812, 10.4161/cc.5.23.3526 · DOI
- Summer, 2019, Activation of the mTORC1/PGC-1 axis promotes mitochondrial biogenesis and induces cellular senescence in the lung epithelium, Am. J. Physiol. Lung Cell Mol. Physiol., 316, L1049, 10.1152/ajplung.00244.2018 · DOI · Paper page
- Zhang, X., Dong, Y., Li, W.C., Tang, B.X., Li, J., and Zang, Y. (2021). Roxithromycin attenuates bleomycin-induced pulmonary fibrosis by targeting senescent cells. Acta Pharmacol. Sin. · DOI
- Kuehl, 2018, BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts, Matrix Biol., 68, 94, 10.1016/j.matbio.2018.01.020 · DOI
- Pan, 2017, Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice, Int J. Radiat. Oncol. Biol. Phys., 99, 353, 10.1016/j.ijrobp.2017.02.216 · DOI · Paper page
- Kaefer, 2014, Mechanism-based pharmacokinetic/pharmacodynamic meta-analysis of navitoclax (ABT-263) induced thrombocytopenia, Cancer Chemother. Pharmacol., 74, 593, 10.1007/s00280-014-2530-9 · DOI · Paper page
- Plate, 2020, The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis, Eur. Respir. Rev., 29, 200269, 10.1183/16000617.0269-2020 · DOI
- Jarman, 2014, An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model, Am. J. Respir. Cell Mol. Biol., 50, 158, 10.1165/rcmb.2013-0174OC · DOI · Paper page
Cited by
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 408
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Alum, E., Izah, S., Uti, D., Ugwu, O., Betiang, P., Basajja, M., & Ejemot-Nwadiaro, R. (2025) · Drug Design, Development and Therapy · doi:10.2147/dddt.s543211 · Cited by 63
Advancing biological understanding of cellular senescence with computational multiomics
Li, S., Agudelo Garcia, P. A., Aliferis, C., Becich, M. J., Calyeca, J., Cosgrove, B. D., Elisseeff, J., Farzad, N., Fertig, E. J., Glass, C., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02314-y · Cited by 40
Self-citationZeyada, M. S., Eraky, S. M., & El-Shishtawy, M. M. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122272 · Cited by 31
Zhong, W., Chen, W., Liu, Y., Zhang, J., Lu, Y., Wan, X., Qiao, Y., Huang, H., Zeng, Z., Li, W., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202200406rr · Cited by 23
Metadata
- Authors
- Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 7012
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3176748518
- Cited by
- 76
- References
- 67
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Instituto de Salud Carlos III (SLT008/18/00176)
- Federación Española de Enfermedades Raras (PI17/00369, 452 PI18/1008, PI19/01152)
- Miguel Servet Research contract (CP16/00039)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cellular Senescence in Lung Fibrosis. https://app.cochat.ai/papers/10.3390/ijms22137012
- The paper
- Hernandez-Gonzalez, F., Faner, R., Rojas, M., Agustí, A., Serrano, M., & Sellarés, J. (2021). Cellular Senescence in Lung Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22137012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.